Literature DB >> 27645109

Tear fluid-eye drops compatibility assessment using surface tension.

Martina Hotujac Grgurević1, Marina Juretić2, Anita Hafner2, Jasmina Lovrić2, Ivan Pepić2.   

Abstract

OBJECTIVE: To evaluate the compatibility of commercially available eye drop surface tension with the tear film physiological range and to characterize commonly used ophthalmic excipients in terms of their surface activity under eye-biorelevant conditions. SIGNIFICANCE: There are a number of quality requirements for the eye drops (e.g. tonicity, pH, viscosity, refractive index) that needs to comply with the physiological parameters of the eye surface. However, the adjustment of surface tension properties of the eye drops to the normal range of surface tension at the air/tear fluid interface (40-46 mN/m) has received rather less attention thus far. Yet, the surface tension at the air/tear fluid interface is of vital importance for the normal function of the eye surface.
METHODS: The surface tension compatibility of the isotonic aqueous solutions of commonly used ophthalmic excipients as well as 18 approved eye drops with the tear fluid have been evaluated using surface tension method.
RESULTS: Each ophthalmic ingredient including the preservatives, solubilizing agents and thickening agents can influence the surface tension of the final formulation. In case of complex ophthalmic formulations one should also consider the possible interactions among excipients and consequent impact on overall surface activity. Out of 18 evaluated eye drops, three samples were within, 12 samples were below and three samples were above the physiological range of the tear fluid surface tension.
CONCLUSIONS: Our results provide a rationale for clinical studies aiming to assess the correlation between the eye drops surface tension and the tear film (in)stability.

Keywords:  Surface activity; ophthalmic formulation development; preservatives; solubilizing agents; thickening agents

Mesh:

Substances:

Year:  2016        PMID: 27645109     DOI: 10.1080/03639045.2016.1238924

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  5 in total

1.  An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival.

Authors:  Josefine C Freiberg; Anne Hedengran; Steffen Heegaard; Goran Petrovski; Jette Jacobsen; Barbara Cvenkel; Miriam Kolko
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 2.  Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control.

Authors:  Agnieszka Gawin-Mikołajewicz; Karol P Nartowski; Aleksandra J Dyba; Anna M Gołkowska; Katarzyna Malec; Bożena Karolewicz
Journal:  Mol Pharm       Date:  2021-09-17       Impact factor: 4.939

3.  Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer.

Authors:  Tivadar Bíró; Gabriella Horvát; Mária Budai-Szűcs; Erzsébet Csányi; Edit Urbán; Andrea Facskó; Piroska Szabó-Révész; Ildikó Csóka; Zoltán Aigner
Journal:  Drug Des Devel Ther       Date:  2018-08-15       Impact factor: 4.162

Review 4.  Image Analysis: A Versatile Tool in the Manufacturing and Quality Control of Pharmaceutical Dosage Forms.

Authors:  Dóra Farkas; Lajos Madarász; Zsombor K Nagy; István Antal; Nikolett Kállai-Szabó
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321

Review 5.  Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants.

Authors:  Ana R Fernandes; Elena Sanchez-Lopez; Tiago Dos Santos; Maria L Garcia; Amelia M Silva; Eliana B Souto
Journal:  Materials (Basel)       Date:  2021-12-08       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.